Not Lost in Translation

Not Lost in Translation

Why do some patients with autoimmune disease respond to treatment while others may not? Understanding these insights can offer scientists potential clues about the underlying cause of disease. This episode, sponsored by AbbVie, explores the approaches scientists use to help drive progress in immunology research like reverse translation – a process that works from “bedside to bench” using clinical observation and patient data to inform and refine drug development earlier on in the process. Not intended for UK audiences. To learn more about AbbVie’s efforts in immunology, visit: https://www.abbvie.com/science/areas-of-focus/immunology.html [https://www.abbvie.com/science/areas-of-focus/immunology.html]

The Answer Is Inside You: The Complexities of Autoimmune Research

The immune system is our greatest defense – a shield that protects us from harmful diseases. But what happens when it misfires and attacks the body with no pathogens in sight? For decades, scientists have been working to find ways to address the conditions that result from this process, like rheumatoid arthritis or lupus. This episode, sponsored by AbbVie, traces how scientists’ understanding of immune activation has evolved and explores new clinical approaches that aim to reset the immune system. It’s a story of turning inward to finding the answers already written in our biology. Not intended for UK audiences. For more information about the technologies and platforms informing AbbVie’s therapeutic approaches, visit: https://abbv.ie/092d64 [https://abbv.ie/092d64]

Beyond the Skin's Surface

What does it really mean to feel good in your own skin? Despite the number of patients who achieve natural-looking results from dermal fillers, social media and online sources have disproportionately amplified stories of the outliers. Providers now play an important role in educating audiences about these medicines – knowledge that can help lead to more informed conversations. In this episode, sponsored by AbbVie, we dive deep into the world of aesthetic medicine, focusing on how education about the science of these treatments can build trust and break down barriers to care. Not intended for UK audiences. For more information about AbbVie’s research in aesthetic medicine, visit: https://www.abbvie.com/science/areas-of-focus/aesthetics.html [https://www.abbvie.com/science/areas-of-focus/aesthetics.html].

Cancer's Clues: How Biomarkers are Changing the Game for Scientists

For patients with tough-to-treat cancers, treatment approaches have advanced significantly over the past several decades. Scientists have made significant progress in understanding cancer biology. In this episode, sponsored by AbbVie, we explore how the discovery of biomarkers – the biological “signatures” for certain cancers – have helped create a paradigm shift in how we treat cancer by focusing on precision medicine approaches to target specific tumors. Not intended for UK audiences. To learn more about AbbVie’s research in oncology, visit: https://www.abbvie.com/science/areas-of-focus/oncology.html [https://www.abbvie.com/science/areas-of-focus/oncology.html].

Smart Packaging

Medication access goes beyond the ability to obtain the medication prescribed – it's also about the logistics: developing, manufacturing and delivering a medicine. This episode, sponsored by AbbVie, explores how teams are rethinking operations and manufacturing to prioritize the most important piece of the puzzle: the patient. Behind every package that reaches a patient lies remarkable science, dedication, and ingenuity, ensuring that care makes it all the way to those who need it most. Not intended for UK audiences. To find out more about AbbVie’s operations and manufacturing capabilities, visit: https://www.abbvie.com/who-we-are/our-stories/how-abbvies-integrated-operations-help-prevent-drug-shortages.html [https://www.abbvie.com/who-we-are/our-stories/how-abbvies-integrated-operations-help-prevent-drug-shortages.html]